Die Dresdner APOGEPHA Arzneimittel GmbH looks back on an eventful company history. Starting in 1882 as a pharmacy, it is now a thrid generation family-owned pharmaceutical enterprise, developing urological drugs and selling beyond Germany as well. The research and development of new products and services in the healthcare sector generates sensitive data that requires special protection. Data loss through criminal acts also poses an existential threat to an innovation company. APOGEPHA is well aware of the risk and wants to train the attention of the employees so that they can recognize threats by phishing attacks via e-mail and thus avert a possible fraud attempt.
„We rehearsed the worst-case scenario and tested it vividly by sending a fictitious phishing e-mail. Our employees were able to experience first-hand what a careless click means.“
Security awareness training for employees to raise awareness of the threat posed by phishing emails.
Setting up and sending test e-mails, evaluating the results and deriving security measures with advice.
Trained employees with heightened awareness of social engineering and development of security measures.
As a traditional drug manufacturer APOGEPHA Arzneimittel GmbH has written Dresden's pharmaceutical history. After its foundation in 1882 by the pharmacist C. Stephan, APOGEPHA developed into today's economically independent, family-owned pharmaceutical company. APOGEPHA currently employs around 150 people.